Kai Jiang

717 total citations
25 papers, 501 citations indexed

About

Kai Jiang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Kai Jiang has authored 25 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in Kai Jiang's work include Streptococcal Infections and Treatments (4 papers), Otolaryngology and Infectious Diseases (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kai Jiang is often cited by papers focused on Streptococcal Infections and Treatments (4 papers), Otolaryngology and Infectious Diseases (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Kai Jiang collaborates with scholars based in China, United States and United Kingdom. Kai Jiang's co-authors include Yaozu Xiang, Yue Xu, Jie Qian, John Hwa, Dandan Wang, Hongcai Shang, Dandan Wang, Yixiang Xu, Sheng Xu and Jian Li and has published in prestigious journals such as Biomaterials, Scientific Reports and European Heart Journal.

In The Last Decade

Kai Jiang

23 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Jiang China 10 220 160 108 94 63 25 501
Yabing Zhang China 9 196 0.9× 163 1.0× 75 0.7× 85 0.9× 39 0.6× 20 544
Liqun Ren China 12 243 1.1× 99 0.6× 96 0.9× 111 1.2× 57 0.9× 37 652
Weijin Fang China 10 224 1.0× 103 0.6× 66 0.6× 64 0.7× 106 1.7× 39 525
Mohammad T. Elnakish United States 15 225 1.0× 203 1.3× 84 0.8× 73 0.8× 27 0.4× 25 526
Gustavo Monnerat Brazil 14 316 1.4× 257 1.6× 41 0.4× 113 1.2× 62 1.0× 34 675
Yichao Xiao China 13 172 0.8× 218 1.4× 66 0.6× 77 0.8× 88 1.4× 56 608
Xingxu Wang China 13 238 1.1× 225 1.4× 77 0.7× 69 0.7× 61 1.0× 27 591
Shinichiro Takashima Japan 15 226 1.0× 254 1.6× 40 0.4× 117 1.2× 36 0.6× 55 633
Anuradha Pandey India 15 252 1.1× 112 0.7× 80 0.7× 71 0.8× 65 1.0× 30 578

Countries citing papers authored by Kai Jiang

Since Specialization
Citations

This map shows the geographic impact of Kai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Jiang more than expected).

Fields of papers citing papers by Kai Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Jiang. The network helps show where Kai Jiang may publish in the future.

Co-authorship network of co-authors of Kai Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Jiang. A scholar is included among the top collaborators of Kai Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Jiang. Kai Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yangzhi, et al.. (2025). Mental well-being of college students: focus on sex differences and psycho physiological indices. BMC Public Health. 25(1). 3038–3038. 1 indexed citations
2.
Jiang, Kai, Yang He, Bingjie Hu, et al.. (2025). Identification of pyroptosis related genes and subtypes in atherosclerosis using multiomic and single cell analysis. Scientific Reports. 15(1). 22360–22360.
3.
Wang, Xuekui, Yue Xu, Canqing Yu, et al.. (2025). Periodontitis-related myocardial fibrosis by expansion of collagen-producing SiglecF+ neutrophils. European Heart Journal. 46(23). 2223–2238. 8 indexed citations
5.
Li, Chao, Da Zheng, Kai Jiang, et al.. (2024). Morphological phenotype of right ventricular outflow tract is associated with cardiovascular outcomes and premature death. Scientific Reports. 14(1). 25128–25128.
6.
Wang, Kun, Kai Jiang, Dongmei Xing, et al.. (2024). Brazilin-Ce nanoparticles attenuate inflammation by de/anti-phosphorylation of IKKβ. Biomaterials. 305. 122466–122466. 9 indexed citations
7.
Yang, Yuxin, et al.. (2023). Quantification of Cardiomyocyte Contraction In Vitro and Drug Screening by MyocytoBeats. Journal of Cardiovascular Translational Research. 16(4). 758–767. 1 indexed citations
8.
Liu, Jiao, Kai Jiang, Shuai Lian, et al.. (2023). The outer membrane protein of Fusobacterium necrophorum, 43K OMP, stimulates inflammatory cytokine production through nuclear factor kappa B activation. Anaerobe. 82. 102768–102768. 1 indexed citations
9.
Xu, Yue, et al.. (2023). A transient wave of Bhlhe41+ resident macrophages enables remodeling of the developing infarcted myocardium. Cell Reports. 42(10). 113174–113174. 28 indexed citations
10.
Xu, Yixiang, Chao Zhang, Kai Jiang, et al.. (2022). Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria. Acta Pharmaceutica Sinica B. 13(4). 1671–1685. 8 indexed citations
11.
Jiang, Kai, Feng Chen, Jie Qian, et al.. (2022). Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia. Biomedicine & Pharmacotherapy. 154. 113606–113606. 14 indexed citations
12.
Jiang, Kai, Shuai Lian, Yaping Chen, et al.. (2022). Interaction of 43K OMP of Fusobacterium necrophorum with fibronectin mediates adhesion to bovine epithelial cells. Veterinary Microbiology. 266. 109335–109335. 6 indexed citations
13.
Xu, Yue, Kai Jiang, Feng Chen, et al.. (2022). Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin. Basic Research in Cardiology. 117(1). 47–47. 28 indexed citations
14.
Wang, Fengfeng, et al.. (2022). Fusobacterium necrophorum Promotes Apoptosis and Inflammatory Cytokine Production Through the Activation of NF-κB and Death Receptor Signaling Pathways. Frontiers in Cellular and Infection Microbiology. 12. 827750–827750. 5 indexed citations
15.
Wang, Dandan, Linyan Lv, Yue Xu, et al.. (2021). Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomedicine & Pharmacotherapy. 136. 111287–111287. 85 indexed citations
16.
Jiang, Kai, Yue Xu, Dandan Wang, et al.. (2021). Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis. Protein & Cell. 13(5). 336–359. 133 indexed citations
17.
Yang, Yingjie, et al.. (2021). CaMKII in Regulation of Cell Death During Myocardial Reperfusion Injury. Frontiers in Molecular Biosciences. 8. 668129–668129. 24 indexed citations
18.
Wang, Lina, He Li, Zhihui Wang, et al.. (2020). Screening of BHK-21 cellular proteins that interact with outer membrane protein 43K OMP of Fusobacterium necrophorum. Anaerobe. 63. 102184–102184. 4 indexed citations
19.
Wang, Dandan, Xiaoyue Hu, Seung Hee Lee, et al.. (2018). Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation. JACC Basic to Translational Science. 3(3). 350–362. 49 indexed citations
20.
Jiang, Kai, Chao Huang, Shuming Ye, & Hang Chen. (2012). High accuracy in automatic detection of atrial fibrillation for Holter monitoring. Journal of Zhejiang University SCIENCE B. 13(9). 751–756. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026